- 期刊
CD44 Splicing Pattern is Associated with Disease Progression in Pulmonary Adenocarcinoma
CD44之接合型與肺腺癌之進行有關
並列摘要
Background and Purpose: Certain alternatively spliced exons of CD44 gene have been associated with specific functions. However, these functions may have come from inclusion of a central array of alternatively spliced exons, rather than a single one The goals of this study were to analyze all of the variant exons included by alternative splicing, the entire population of CD44 mRNA transcripts and the prognostic implications of CD44 mRNA and protein isoforms expressed by non-small cell lung cancer (NSCLC). Method: Using a polymerase chain reaction protocol with short reaction times, we amplified seqnenced and quantified CD44 mRNA transcripts from 52 samples of NSCLC to determine the splicing patterns of alternatively included exons and the proportion of each CD44 mRNA transcript. The expression of CD44 standard form and. variant isoforms CD44v3 and CD44v6 were also analyzed by immunohistochemistry (IHC). Results: Normal lung and NSCLC expressed CD44 mRNA transcripts containing variant exons vl0; v8-10, v6-10, v3-10 and v2-10. In squamous cell carcinoma, the expression rates of these mRNA transcripts were equal to or higher than those of the normal lung, and the splicing pattern was not associated with disease progression. In adenocarcinoma, the expression rates of CD44v6-10, v3-10 and v2-10 mRNA were lower than in normal lung. The down-regulation of CD44v6-10, CD44v3-10 mRNA and CD44v6 protein paralleled the progression of adenocarcinoma. Recurrence of adenocarcinoma was associated with negative expression of CD44v6-10pr CD44v3-10 mRNA, and with low-level expression, of CD44v6 or CD44v3, by IHC. Negative expression of CD446-10 mRNA and reduced expression of CD44v6 protein were associated with a shorter disease free and overall survival in the univariate but not the multivariate analysis. Conclusion: Our data suggest that CD44 splicing pattern is associated with disease progression in adenocarcinoma.
延伸閱讀
- Hsieh, Y. C., Lin, C. L., Tsao, C. J., Hsieh, P. P., Tzeng, C. C., & Chuang, S. S. (2009). 有套細胞淋巴瘤病史的病人得到化療相關性急性骨髓性白血病於週邊血液出現同時表現CD19及CD43的血癌細胞. The Kaohsiung Journal of Medical Sciences, 25(7), 389-394. https://www.airitilibrary.com/Article/Detail?DocID=1607551X-200907-200907170052-200907170052-389-394
- 康婉儀（2005）。CD66a在大腸直腸腺瘤及腺癌中的表現及其可能扮演的角色〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2903200614025574
- 林聖哲（2022）。CDKN2B-AS1基因多型性及環境因子對肺癌易感性之影響〔碩士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/csmu202200183
- 李詩儀（2007）。肺腺細胞癌上游調節基因與惡性腫瘤關聯之確認〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-2901200818232500
- Chang, W. T., Wu, C. C., Hung, C. C., Chen, M. Y., Fang, C. T., Chen, W. J., Chuang, C. Y., & Lee, Y. T. (2003). 後天免疫不全病毒感染之左心室功能異敘主要主要與CD4淋巴球數目相關而非伺機感染. Journal of the Formosan Medical Association, 102(3), 158-163. https://doi.org/10.29828/JFMA.200303.0005